Trial intelligence / Profile preview

Aspirin Complex vs Components for Cold Symptoms

NCT01062360Phase 3Completed

Sponsor
Bayer
Start
Dec 2005
Primary completion
May 2007
Modality
Orthosteric Ligands
Countries
4
01

Overview

Phase 3, randomised, double-blind trial of aspirin and pseudoephedrine in common cold and pharyngitis (4 arms), sponsored by Bayer. Primary endpoints: Area Under the Curve for Nasal Congestion Score at 2 hours and Sum of Pain Intensity Difference at 2 hours. Started Dec 2005; status: completed.

02

Drugs

aspirinpseudoephedrine
03

Conditions

common coldpharyngitis

Beyond the preview

Go deeper on NCT01062360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01062360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call